DSIP Trifluoroacetate dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (100 mcg @ 75 kg). Educational only — never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 62–84 mcg | 0.06–0.08 mL | 3–3 units0.02–0.03 mL | — |
| 60–75 kg / 132–165 lb | 77–103 mcg | 0.08–0.10 mL | 3–4 units0.03–0.04 mL | — |
| 75–90 kg / 165–198 lb | 94–126 mcg | 0.09–0.13 mL | 4–5 units0.04–0.05 mL | — |
| 90–105 kg / 198–231 lb | 111–150 mcg | 0.11–0.15 mL | 4–6 units0.04–0.06 mL | — |
| >105 kg / >231 lb | 128–173 mcg | 0.13–0.17 mL | 5–7 units0.05–0.07 mL | — |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for DSIP Trifluoroacetate; the elapsed-time column is hidden.
DSIP Trifluoroacetate by goal
Read DSIP Trifluoroacetate's profile and dosing through a specific research-goal lens.
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.